 |
| 20-May-13 | Downgrade |
Northland Capital |
Outperform → Market Perform |
|
|
| 04-Feb-13 | Reiterated |
Northland Capital |
Outperform |
$16 → $20 |
|
| 07-Sep-12 | Initiated |
Northland Securities |
Outperform |
$16 |
|
| 25-Apr-12 | Reiterated |
Barrington Research |
Outperform |
$11 → $13 |
|
| 19-Mar-12 | Reiterated |
Canaccord Genuity |
Buy |
$12 → $14.50 |
|
| 29-Jul-10 | Reiterated |
Rodman & Renshaw |
Mkt Outperform |
$12 → $9 |
|
| 08-Jan-10 | Initiated |
Rodman & Renshaw |
Mkt Outperform |
$12 |
|
| 30-Dec-09 | Reiterated |
Canaccord Adams |
Buy |
$9 → $11 |
|
| 26-Oct-09 | Upgrade |
Stifel Nicolaus |
Hold → Buy |
$8 |
|
| 11-Sep-09 | Upgrade |
Canaccord Adams |
Hold → Buy |
$4 → $8 |
|
| 24-Jul-09 | Reiterated |
Caris & Company |
Average |
$4 → $6 |
|
| 24-Jul-09 | Downgrade |
Jefferies & Co |
Buy → Hold |
$5 |
|
| 20-Feb-09 | Reiterated |
Jefferies & Co |
Buy |
$7 → $4 |
|
| 09-Jan-09 | Reiterated |
Roth Capital |
Buy |
$7.50 → $4.50 |
|
| 09-Jan-09 | Reiterated |
Jefferies & Co |
Buy |
$8 → $7 |
|
| 13-Nov-08 | Initiated |
Stifel Nicolaus |
Hold |
|
|
| 03-Oct-08 | Initiated |
Caris & Company |
Average |
$5 |
|
| 16-Sep-08 | Reiterated |
Roth Capital |
Buy |
$9 → $7.50 |
|
| 05-Sep-08 | Reiterated |
Roth Capital |
Buy |
$12.50 → $9 |
|
| 05-Sep-08 | Reiterated |
Canaccord Adams |
Hold |
$11 → $6 |
|
|
|
| 20-May-13 12:20AM | Spectranetics downgraded by Northland Capital Briefing.com |
| 15-May-13 01:04PM | SPECTRANETICS CORP Financials EDGAR Online Financials |
| 09-May-13 07:00AM | SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 06-May-13 04:04PM | InPlay: Spectranetics announces FDA approval of its adjunct analysis plan associated with the EXCITE ISR clinical trial, studying the treatment of in-stent restenosis in the legs Briefing.com |
| 04:01PM | Spectranetics Finalizes EXCITE ISR Adjunct Analysis Plan GlobeNewswire |
| 01-May-13 04:06PM | Spectranetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Over-Allotment Option GlobeNewswire |
| 09:38AM | Insiders Bullish on Certain Holdings of IWC at Forbes |
| 26-Apr-13 02:53PM | 4 Stocks Rising on Unusual Volume at TheStreet |
| 03:58AM | SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements EDGAR Online |
| 25-Apr-13 07:00PM | Spectranetics Prices Public Offering of Common Stock GlobeNewswire +5.42% |
| 06:03PM | Nasdaq stocks posting largest percentage decreases AP |
| 07:35AM | Spectranetics upgraded to Outperform from Market Perform at Barrington at theflyonthewall.com |
| 24-Apr-13 06:02PM | Nasdaq stocks posting largest percentage decreases AP -10.01% |
| 01:28PM | Nasdaq stocks posting largest percentage decreases AP |
| 23-Apr-13 07:37PM | Spectranetics' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 05:34PM | The Spectranetics Earnings: Everything You Must Know Now at Wall St. Cheat Sheet |
| 04:04PM | InPlay: Spectranetics announces 4.75 mln share common stock offering Briefing.com |
| 04:03PM | Spectranetics Announces Common Stock Offering GlobeNewswire |
| 04:01PM | Spectranetics Achieves First Quarter Revenue of $37.7 Million GlobeNewswire |
| 09:06AM | SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online |
| 07:07AM | Q1 2013 Spectranetics Earnings Release - After Market Close CCBN |
| 11-Apr-13 04:50PM | Spectranetics to Hold 2013 First Quarter Financial Results Conference Call on April 23 GlobeNewswire |
| 22-Mar-13 01:02AM | 1 Reason to Expect Big Things from Spectranetics at Motley Fool |
| 19-Mar-13 01:04PM | SPECTRANETICS CORP Financials EDGAR Online Financials |
| 12:24PM | Opportunities Rise in Advanced Surgical Technology as Patients Want Predictable Outcomes, Hospitals Want Predictable Supply and Costs and Payers Want Reassurance on Implant Precision Wall Street Transcript |
| 13-Mar-13 04:52PM | SPECTRANETICS CORP Files SEC form 10-K, Annual Report EDGAR Online |
| 11-Mar-13 04:25PM | Spectranetics files $250M mixed securities shelf theflyonthewall.com |
| 08-Mar-13 05:00PM | Finding the Next Home Run Stock at Motley Fool |
| 04:32PM | SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 26-Feb-13 04:57PM | Spectranetics' CEO Presents at Citi 2013 Global Healthcare Conference (Transcript) at Seeking Alpha |
| 23-Feb-13 08:14PM | New Star Analyst Rankings for The Spectranetics Corporation StarMine |
| 10:09AM | 5 Stocks Beat Traders Expectations at Wall St. Cheat Sheet |
| 22-Feb-13 07:27PM | New Star Analyst Rankings for The Spectranetics Corporation StarMine |
| 12:11PM | Spectranetics Beats on Revenue, Matches Expectations on EPS at Motley Fool |
| 21-Feb-13 05:35PM | Spectranetics' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 01:33PM | The Spectranetics Earnings: Heres Why the Stock is Up Now at Wall St. Cheat Sheet |
| 09:27AM | SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online |
| 07:07AM | Q4 2012 Spectranetics Earnings Release - Before Market Open CCBN |
| 06:00AM | Spectranetics Achieves Fourth Quarter Revenue of $36.8 Million GlobeNewswire |
| 19-Feb-13 04:05PM | Spectranetics to Participate in the Citi 2013 Global Healthcare Conference GlobeNewswire |
| 01:14AM | Can Spectranetics Meet These Numbers? at Motley Fool |
| 07-Feb-13 11:51AM | Insiders Bullish on Certain Holdings of IWC at Forbes |
| 29-Jan-13 07:31AM | InPlay: Spectranetics announces expansion into Japan peripheral intervention market; quick-cross support catheter receives regulatory and reimbursement approval Briefing.com |
| 07:30AM | Spectranetics Announces Expansion Into Japan Peripheral Intervention Market GlobeNewswire |
| 28-Jan-13 08:00AM | Spectranetics to Hold 2012 Fourth Quarter Financial Results Conference Call on February 21 GlobeNewswire |
| 24-Jan-13 07:03AM | InPlay: Spectranetics: Final results of Spectranetics study supports successful use of laser atherectomy for treating patients with peripheral in-stent restenosis Briefing.com |
| 07:00AM | Final Results of Spectranetics Study Supports Successful Use of Laser Atherectomy for Treating Patients With Peripheral In-Stent Restenosis GlobeNewswire |
| 14-Jan-13 09:02AM | Checking an Important, Overlooked Metric at Spectranetics at Motley Fool |
| 11-Jan-13 02:11PM | SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 07-Jan-13 07:43AM | Spectranetics purchases Upstream Peripheral Technologies for $5.5M theflyonthewall.com |
| 07:34AM | SPECTRANETICS CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and E EDGAR Online |
| 07:34AM | InPlay: Spectranetics announces agreement to purchase the assets of Upstream Peripheral Technologies for up-front consideration of $5.5 mln; co expects to generate positive cash flow from the transaction in 2013 Briefing.com |
| 07:30AM | The Spectranetics Corporation Strengthens Vascular Portfolio With Purchase of Upstream Peripheral Technologies, Ltd GlobeNewswire |
| 27-Dec-12 04:05PM | Spectranetics to Present at the 31st Annual J.P. Morgan Healthcare Conference GlobeNewswire |
| 26-Dec-12 10:24AM | Insiders Buy the Holdings of IWC at Forbes |
| 19-Dec-12 04:59PM | Colorado stocks: Good Times up 8%; Prospect Global, Gevo up 7% at bizjournals.com |
| 03-Dec-12 09:02AM | 1 Reason to Expect Big Things from Spectranetics at Motley Fool |
| 26-Nov-12 05:30PM | [$$] MedAssets CEO Sells Near Share-Price Highs at Barrons.com |
| 16-Nov-12 04:49PM | Spectranetics to Participate in the 24th Annual Piper Jaffray Healthcare Conference GlobeNewswire |
| 14-Nov-12 01:04PM | SPECTRANETICS CORP Financials EDGAR Online Financials -5.01% |
| 07-Nov-12 03:44PM | SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 01-Nov-12 01:17PM | Spectranetics Beats on Revenue, Matches Expectations on EPS at Motley Fool |
| 30-Oct-12 10:36AM | SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online |
| 08:58AM | Spectranetics downgraded by Barrington Research Briefing.com |
| 07:07AM | Q3 2012 Spectranetics Earnings Release - Before Market Open CCBN |
| 06:09AM | InPlay: Spectranetics beats by $0.01, beats on revs; raises bottom end of FY12 EPS in-line, revs in-line Briefing.com |
| 06:00AM | Spectranetics Achieves Third Quarter Revenue of $35.2 Million GlobeNewswire |
| 27-Oct-12 02:14AM | Are You Expecting This from Spectranetics? at Motley Fool |
| 16-Oct-12 04:05PM | Spectranetics to Hold 2012 Third Quarter Financial Results Conference Call on October 30 GlobeNewswire |
| 08-Oct-12 04:17PM | Spectranetics announces U.S. launch of TAPAS catheter theflyonthewall.com |
| 04:10PM | Spectranetics Announces U.S. Launch of the TAPAS(TM) Catheter and Preclinical Animal Data on Drug Uptake in Peripheral Vessels GlobeNewswire |
| 05-Oct-12 12:00PM | SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online |
| 12-Sep-12 10:11AM | Equity Brief: Upgrades and Downgrades for September 11th: ALL, CCI, DG, FDO, GS, HSY, HTGC, LINTA, LLL, MWIV Thomson Reuters ONE |
| 07-Sep-12 01:48PM | Heartware INITIATED at Under Perform and 3 Analyst-Initiated Shares to Notice at Wall St. Cheat Sheet |
| 10:20AM | Equity Brief: Upgrades and Downgrades for September 7th: MLNX, MN, MPR, MTSI, MUSA, NSC, NUVA, NVDA, NXTM Thomson Reuters ONE |
| 01:20AM | Coverage initiated on Spectranetics by Northland Securities Briefing.com |
| 23-Aug-12 05:27PM | Spectranetics to Participate in Upcoming Investor Conferences GlobeNewswire |
| 20-Aug-12 08:41AM | 1 Reason to Expect Big Things from Spectranetics at Motley Fool |
| 15-Aug-12 02:24PM | Percutaneous Coronary Intervention (PCI) Surgical Device from Abiomed (ABMD) Approved in Europe and Canada: CEO Sees 30% Growth Rate Continuing Wall Street Transcript |
| 14-Aug-12 01:04PM | SPECTRANETICS CORP Financials EDGAR Online Financials |
| 07-Aug-12 05:21PM | SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 02-Aug-12 04:02PM | Spectranetics to Present at the 32nd Annual Canaccord Genuity Growth Conference GlobeNewswire |
| 31-Jul-12 05:00AM | Spectranetics Corporation Stock Downgraded (SPNC) at TheStreet |
| 27-Jul-12 10:48AM | New Star Analyst Rankings for The Spectranetics Corporation StarMine |
| 08:50AM | Watsons Concerta REMAINS Approvable and 4 Stocks Enjoying 52-Week Highs at Wall St. Cheat Sheet |
| 26-Jul-12 03:50PM | Healthcare Review: Genetic Technologies, Celgene & Synta Pharmaceuticals Are Mid Day Leaders Thomson Reuters ONE +18.03% |
| 03:18PM | Healthcare Review: Genetic Technologies, Celgene & Synta Pharmaceuticals Are Mid Day Leaders Thomson Reuters ONE |
| 11:00AM | Spectranetics Earnings Call scheduled for 11:00 am ET today CCBN |
| 10:48AM | Equity Briefing: Earnings Results for July 26th: PACR, PCP, PCS, PHM, PLD, PMTI, POT, PSSI, PTEN, QSII, RCL, R Thomson Reuters ONE |
| 09:48AM | SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online |
| 07:40AM | Spectranetics Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:07AM | Q2 2012 Spectranetics Earnings Release - Before Market Open CCBN |
| 06:18AM | InPlay: Spectranetics beats by $0.01, beats on revs; reaffirms FY12 EPS guidance, raises FY12 revs above consensus Briefing.com |
| 06:00AM | Spectranetics Achieves Second Quarter Revenue of $35.0 Million GlobeNewswire |
| 18-Jul-12 04:05PM | Spectranetics to Hold 2012 Second Quarter Financial Results Conference Call on July 26 GlobeNewswire |
| 02-Jul-12 10:51PM | Hidden Small Cap Medical Device Companies with Big Growth Potential at Motley Fool |
| 18-Jun-12 11:23AM | 1 Reason to Expect Big Things From Spectranetics at Motley Fool |
| 01-Jun-12 12:36PM | SPECTRANETICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 07:00AM | Spectranetics Appoints B. Kristine Johnson as Director Business Wire |
| 30-May-12 09:56AM | DBJ Tech Watch for Wednesday: Apple, Facebook, HP, Red Herring Top 100 at bizjournals.com |
|
|
| The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to access and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads. The company's vascular intervention product line includes peripheral atherectomy, a range of laser catheters for ablation of blockages in arteries above and below the knee; crossing solutions, which support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions; coronary atherectomy and thrombectomy, which are aspiration and cardiac laser catheters for the treatment of blockages in the heart; and drug delivery catheters for vascular delivery of drugs and diagnostic agents. Its primary vascular intervention products include the Turbo Elite and Turbo-Tandem laser catheters and the TAPAS drug delivery catheters for peripheral atherectomy; crossing catheters, such as the Quick-Cross, Quick-Cross Select, and Quick-Cross Extreme; the ELCA Laser Ablation Catheter for coronary atherectomy; and QuickCat aspiration catheter for thrombus management. Its lead management product line comprises excimer laser sheaths, non-laser sheaths, and cardiac lead management accessories, such as Spectranetics Laser Sheath, GlideLight, and Lead Locking Device for the removal of pacemaker and defibrillator cardiac leads. The company sells its products in the United States, Canada, Europe, the Middle East, the Asia Pacific, Latin America, and Puerto Rico. The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, Colorado. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Bowe Wade A | Vice President R&D | Apr 15 | Option Exercise | 0.00 | 2,500 | 0 | 14,765 | Apr 17 06:17 PM | | CHILDS GUY A | CFO | Apr 15 | Option Exercise | 0.00 | 6,700 | 0 | 139,097 | Apr 17 06:16 PM | | Matin Shahriar | Sr VP of Ops, Bus. Dev., Intl | Apr 15 | Option Exercise | 0.00 | 4,375 | 0 | 26,395 | Apr 17 06:16 PM | | Hein Jason D | Sr. VP Commercial Operations | Apr 15 | Option Exercise | 0.00 | 4,375 | 0 | 64,184 | Apr 17 06:17 PM | | Bowe Wade A | Vice President R&D | Mar 19 | Option Exercise | 3.08 | 938 | 2,889 | 12,265 | Mar 21 04:42 PM | | Hein Jason D | Sr. VP Commercial Operations | Mar 04 | Option Exercise | 2.74 | 3,000 | 8,220 | 62,809 | Mar 05 03:44 PM | | Hein Jason D | Sr. VP Commercial Operations | Mar 04 | Sale | 18.54 | 3,000 | 55,610 | 59,809 | Mar 05 03:44 PM | | RUGGIO JOSEPH M | Director | Dec 04 | Option Exercise | 3.80 | 8,033 | 30,525 | 78,190 | Dec 05 04:52 PM | | RUGGIO JOSEPH M | Director | Dec 04 | Sale | 14.08 | 18,630 | 262,364 | 59,560 | Dec 05 04:52 PM | | Hein Jason D | Sr. VP Commercial Operations | Dec 04 | Sale | 14.10 | 1,289 | 18,175 | 59,809 | Dec 05 04:51 PM | | RUGGIO JOSEPH M | Director | Dec 03 | Option Exercise | 3.80 | 36,967 | 140,475 | 80,073 | Dec 05 04:52 PM | | RUGGIO JOSEPH M | Director | Dec 03 | Sale | 14.22 | 9,916 | 140,977 | 70,157 | Dec 05 04:52 PM | | Hein Jason D | Sr. VP Commercial Operations | Dec 03 | Sale | 14.22 | 9,911 | 140,906 | 61,098 | Dec 05 04:51 PM | | FLETCHER R JOHN | Director | Nov 02 | Buy | 13.86 | 1,000 | 13,861 | 79,562 | Nov 05 04:20 PM | | Drake Scott William | President, CEO | Nov 02 | Buy | 14.18 | 7,000 | 99,260 | 27,365 | Nov 05 04:20 PM | | Walker Craig W | Director | Oct 11 | Option Exercise | 5.32 | 15,000 | 79,800 | 448,353 | Oct 15 03:31 PM | | Drake Scott William | President, CEO | Aug 10 | Option Exercise | 0.00 | 12,500 | 0 | 25,500 | Aug 14 06:16 PM | | Boehme Lisa Renee | VP & GM Sales, Mktg Lead Mgmt | Jun 01 | Option Exercise | 0.00 | 1,250 | 0 | 28,688 | Jun 04 05:43 PM | | Bowe Wade A | Vice President Mfg & Develpmnt | Jun 01 | Option Exercise | 0.00 | 2,075 | 0 | 11,972 | Jun 04 05:43 PM | | CHILDS GUY A | CFO | Jun 01 | Option Exercise | 0.00 | 2,925 | 0 | 134,397 | Jun 04 05:42 PM | | Hein Jason D | Sr. VP & GM Sales, Mktg VI | Jun 01 | Option Exercise | 0.00 | 2,500 | 0 | 71,786 | Jun 04 05:41 PM | | Wertheimer Roger | VP, General Counsel, Secretary | Jun 01 | Option Exercise | 0.00 | 3,750 | 0 | 9,800 | Jun 04 05:40 PM | | Matin Shahriar | Sr VP of Ops, Prod. Dev., Intl | Jun 01 | Option Exercise | 0.00 | 2,500 | 0 | 22,797 | Jun 04 05:36 PM | | FLETCHER R JOHN | Director | May 25 | Buy | 9.93 | 6,000 | 59,556 | 72,483 | May 29 03:26 PM |
|
|
|
|
|
|
